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Cationic NLCs represent lipid vesicles bearing cationic lipids on its surface, which leads to 
electrostatic interactions with negative charges of the nucleic acids such as miRNA and 
formation of a complex which protect the nucleic acids from the inevitable physicochemical 
biological impacts within the blood circulation [1]. This study aimed to develop cNLCs in order 
to obtain the most suitable formulation for further delivery of miRNAs.  
cNLCs containing stearylamine, Precirol® ATO 5 and Miglyol® 812 in the lipid phase and 
different concentrations of Poloxamer® 188 and Tween® 80 in the aqueous phase were 
prepared by the high-pressure homogenization method. In order to evaluate appropriate 
process parameters for NLC preparation, different cycle numbers (1-5) and homogenization 
pressures (500 bar, 650 bar and 800 bar) were tested. Additionally, the influence of the cooling 
technique was investigated. cNLCs were characterized regarding particle size, particle size 
distribution, zeta potential, and crystallinity using photon correlation spectroscopy technique 
and laser diffraction, electrophoretic light scattering, and differential scanning calorimetry, 
respectively.  
The obtained particle size of all formulations was between 80 and 180 nm, and it decreased 
significantly with the increase of non-ionic surfactant concentration. Furthermore, particle 
size decreased with the increase of the homogenization cycles. The surface charge value was 
highly positive in formulations (+32 to +41 mV), demonstrating the successful incorporation 
of stearylamine onto the nanoparticle surface. However, the cooling technique did not have a 
significant impact on the particle size of cNLCs. 
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